The story of GLP-1 drugs keeps getting bigger. First they transformed the treatment of diabetes. Then they upended the ...

A retrospective analysis of more than 110,000 women between the ages of 45 and 80 found that those who took GLP-1 medications ...

Scientists have identified proteins that could signal increased lung cancer risk, as well as a drug that could reduce the ...

NSCLC showed the largest reduction in metastatic progression with GLP-1RAs versus gliptins (HR 0.50), with significant benefits also in breast (HR 0.57), colorectal (HR 0.69), and HCC (HR 0.62).

Treating breast cancer remains a major medical challenge worldwide. This is largely due to the ability of breast cancer cells ...

A University of Minnesota Medical School-led research team has discovered that a cancer signaling pathway has previously unrecognized roles in retina and brain blood vessels. The findings were ...

For most children diagnosed with medulloblastoma, the most common malignant pediatric brain tumor, survival rates are ...

Scientists have uncovered a surprising new way the immune system fights cancer, overturning a core belief that has guided ...

Dynamic clinical pathways are essential to keep pace with rapid advancements in oncology treatments and FDA approvals. Inclusive participation and effective communication are vital for pathway ...

Patients with metastatic pancreatic cancer who had already failed at least one round of chemotherapy lived roughly twice as ...